GI
INDV icon

GAMMA Investing’s Indivior Pharmaceuticals INDV Stock Holding History

GAMMA Investing’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.1K Buy
1,612
+1,115
+224% +$40.4K ﹤0.01% 2112
2026
Q1 		$15.1K Sell
497
-702
-59% -$23.2K ﹤0.01% 2866
2025
Q4 		$43K Buy
1,199
+1,013
+545% +$30.9K ﹤0.01% 2168
2025
Q3 		$4.48K Buy
+186
New +$3.89K ﹤0.01% 3217

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

GAMMA Investing's INDV Position: Q2 2026 in Review

GAMMA Investing increased its Indivior Pharmaceuticals (INDV) stake by 224% in Q2 2026, buying an estimated $40.4K and bringing the position to 1,612 shares worth $66.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

GAMMA Investing first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • GAMMA Investing held 1,612 shares of Indivior Pharmaceuticals worth $66.1K as of Q2 2026.
  • GAMMA Investing bought 1,115 Indivior Pharmaceuticals shares in Q2 2026, an estimated $40.4K.
  • Indivior Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2112 holding.
  • GAMMA Investing first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.